Money, Fiance News, Press Release Distribution
Financial News and Press Release Distribution Services

Submit RSS Feed | About US | Contact Us





Home | Personal Finance News | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

Money News Media
Bankrate
CNBC
CNNMoney
Finacial Times
FOX Business
Moneynews


Money News Now


USNews
Reuters Money
RSS News Feed
Get your news feed listed here as other news media shown above! Submit RSS News Feed

Personal Finance News Releases

Global Post Menopausal Vaginal Atrophy Drugs Market Key Trends, Size, Growth, Shares And Forecast Research Report 2016-2020

 



(MoneyNewsWire.Net, May 05, 2016 )
Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA.

Technavios analysts forecast the global PVA drugs market to grow at a CAGR of 7.13% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global PVA drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of drugs (creams, tablets, patches, and rings) used to treat PVA.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=711490

The market is divided into the following segments based on geography:
Americas
EMEA
APAC

Latest report, Global Post-Menopausal Vaginal Atrophy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Pfizer Inc.
Allergan Inc.
Shionogi & Co. Ltd.
Novo Nordisk A/S
Teva Pharmaceutical Industries Ltd.

Other prominent vendors
Bayer
Bionovo
EndoCeutics
Foamix Pharmaceuticals
Ligand Pharmaceuticals
Pantarhei Bioscience
Pep-Tonic Medical
TherapeuticsMD
Upsher-Smith Laboratories

Market driver
Favorable healthcare reforms in the US
For a full, detailed list, view our report

Market challenge
Patent expiry of branded products
For a full, detailed list, view our report

Market trend
Paradigm shift to non-estrogenic therapies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse Detail Report With TOC @ http://www.researchmoz.us/global-post-menopausal-vaginal-atrophy-drugs-market-2016-2020-report.html

Table Of Content

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
Assumptions
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
Key buying criteria
PART 05: Overview: Vaginal atrophy
Symptoms
Causes
Pathophysiology
Diagnosis
Treatment
Epidemiology
PART 06: Branded drug profiles
Activella
Enjuvia
Estrace
Femring
Premarin
Osphena
Vagifem
PART 07: Market landscape
Market overview
Market size and forecast
PART 08: Market segmentation by drug class
Topical estrogen
Systemic estrogen
PART 09: Geographical segmentation
Global PVA drugs market by geographical segmentation 2015-2020
PVA drugs market in Americas
PVA drugs market in US
PVA drugs market in EMEA
PVA drugs market in Europe
PVA drugs market in APAC
PVA drugs market in Japan
PART 10: Market drivers
Significant unmet medical needs
Favorable healthcare reforms in US
Increase in awareness of PVA
Cost-effective OTC drugs
PART 11: Impact of drivers
PART 12: Market challenges
Patent expiry of branded products
Low diagnosis rates
Poor patient adherence
Side effects of drugs
PART 13: Impact of drivers and challenges
PART 14: Market trends
Paradigm shift to non-estrogenic therapies
Increased R&D
Patient assistance programs
Strategic alliances
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2015
Pfizer
Allergan
Shionogi
Novo Nordisk
Teva Pharmaceutical
Other prominent vendors
PART 16: Appendix
List of abbreviations

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=711490

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease

Researchmoz Global Pvt.Ltd

Researchmoz

+1-518-621-2074

sales@researchmoz.us

Source: EmailWire.Com


Personal Finance News
  • Auto
  • CDs
  • College
  • Credit Cards
  • Insurance
  • Mortgage
  • Mutual Funds
  • Retirement
  • Savings
  • Taxes

  • Money RSS Marketpalce

    Free Finance Magazines Downloads
    Get free publications including magazines, white papers on finance, investments.
    Submit RSS news feed on Finance, Investment.
    Have your feed on news, products or services displayed under this marketpalce. The feed also displayed on a full page and updated daily.



    Money NewsWire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    Money-NewsWire.Net - Newswire and Press Release service of GroupWeb Media LLC